117 related articles for article (PubMed ID: 2518743)
21. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
22. Differences identified between serum and urine immunofixation electrophoresis.
Tracy E; Andrews DM; Constantin MA; Zhu Y
Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209
[TBL] [Abstract][Full Text] [Related]
23. Abnormal N-glycosylation of the immunoglobulin G kappa chain in a multiple myeloma patient with crystalglobulinemia: case report.
Hashimoto R; Toda T; Tsutsumi H; Ohta M; Mori M
Int J Hematol; 2007 Apr; 85(3):203-6. PubMed ID: 17483055
[TBL] [Abstract][Full Text] [Related]
24. [Diclonal gammopathy (IgG kappa, IgA lambda) with nephrotic syndrome terminating into IgA lambda myeloma after three years--report of a case].
Shigemi H; Murakami S; Oku N; Itoh K; Fujita N; Nakanishi S; Shimazaki C; Inoue D; Takahashi H; Nakagawa M
Rinsho Ketsueki; 1990 Feb; 31(2):209-13. PubMed ID: 2109804
[TBL] [Abstract][Full Text] [Related]
25. Structural studies of three IgG kappa proteins from a patient with multiple myeloma.
Dworsky E; Sletten K; Harboe M; Wetteland P
Scand J Immunol; 1980; 12(4):281-7. PubMed ID: 6781064
[TBL] [Abstract][Full Text] [Related]
26. Overrepresentation of the V kappa IV subgroup in light chain deposition disease.
Denoroy L; Déret S; Aucouturier P
Immunol Lett; 1994 Sep; 42(1-2):63-6. PubMed ID: 7829131
[TBL] [Abstract][Full Text] [Related]
27. [An unusual case of multiple myeloma diagnosed by a noticeable decrease in the serum M-component level].
Kanoh T
Rinsho Ketsueki; 1996 Dec; 37(12):1416-21. PubMed ID: 8997132
[TBL] [Abstract][Full Text] [Related]
28. A biclonal origin of two monoclonal proteins, IgG3(kappa) and IgA1(lambda), from a single patient.
Ockhuizen T; Steen G; Muilerman HG; Smit JW; Wietzes P; Mandema E; Marrink J
Immunology; 1979 Aug; 37(4):863-8. PubMed ID: 115782
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin heavy and light chain isotypes in multiple myeloma patients.
Ansari NA; Owais M; Usha
Asian Pac J Cancer Prev; 2007; 8(4):593-6. PubMed ID: 18260735
[TBL] [Abstract][Full Text] [Related]
30. Biclonal gammopathy (IgG kappa and IgG lambda) in a patient with non-Hodgkin's lymphoma.
Guarner J; Austin GE; Nassar VH; Sarma PR; Boedecker E
Arch Pathol Lab Med; 1986 May; 110(5):445-8. PubMed ID: 3083801
[TBL] [Abstract][Full Text] [Related]
31. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
32. MALDI-TOF mass spectrometry can distinguish immunofixation bands of the same isotype as monoclonal or biclonal proteins.
Fatica EM; Martinez M; Ladwig PM; Murray JD; Kohlhagen MC; Kyle RA; Kourelis T; Lust JA; Snyder MR; Dispenzieri A; Murray DL; Willrich MAV
Clin Biochem; 2021 Nov; 97():67-73. PubMed ID: 34384797
[TBL] [Abstract][Full Text] [Related]
33. [Unusual multiple myeloma: biclonal gammopathy associated with hyperlipidemia].
Rodríguez Fuchs C; de Pizzolato M; Marín C; Serramalera M; Tezanos Pinto M
Sangre (Barc); 1986; 31(3):360-6. PubMed ID: 3092377
[No Abstract] [Full Text] [Related]
34. Complex IgA gammopathy in Gaucher's disease.
Shvidel L; Hurwitz N; Shtalrid M; Zur S; Oliver O; Berrebi A
Leuk Lymphoma; 1995 Dec; 20(1-2):165-8. PubMed ID: 8750640
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
Yang JJ; Zhang GS; Chen XR
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
[TBL] [Abstract][Full Text] [Related]
36. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.
Barnidge DR; Dasari S; Botz CM; Murray DH; Snyder MR; Katzmann JA; Dispenzieri A; Murray DL
J Proteome Res; 2014 Mar; 13(3):1419-27. PubMed ID: 24467232
[TBL] [Abstract][Full Text] [Related]
37. Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).
van de Donk NW; Otten HG; El Haddad O; Axel A; Sasser AK; Croockewit S; Jacobs JF
Clin Chem Lab Med; 2016 Jun; 54(6):1105-9. PubMed ID: 26812873
[TBL] [Abstract][Full Text] [Related]
38. Late appearance of an IgA (kappa) monoclonal protein in a patient with IgG (kappa) multiple myeloma: sharing of idiotypic specificities between the two serum proteins.
Scolari L; Vaerman JP; Castigli E; Voliani D; Salsano F; Masala C; Di Guglielmo R
Scand J Immunol; 1978; 8(3):201-6. PubMed ID: 100871
[TBL] [Abstract][Full Text] [Related]
39. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A
Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419
[TBL] [Abstract][Full Text] [Related]
40. Human myeloma IgA half-molecules.
Spiegelberg HL; Fishkin BG
J Clin Invest; 1976 Nov; 58(5):1259-65. PubMed ID: 993344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
